• Small Molecules
      • Discovery
        Development
        Manufacturing
    • Biologics
      • Discovery
        Development & Manufacturing
    • Other Drug Modalities
    • SynVent Integrated Drug Discovery

      • SynVent Integrated Drug Discovery

        SynVent is Syngene’s platform for fully integrated therapeutic discovery and development across large and small molecules. 

        Know More
        Know More
    • Industries
    • Emerging Biopharma

      • Emerging Biopharma

        Emerging biopharma work at the forefront of science, often venturing into disease areas where little or no real-world data exists to work with or regulatory frameworks to work within.

        Know More
        Know More
    • Dedicated Centers

      • Dedicated Centers

        Our Dedicated Centers offer dedicated multi-disciplinary scientific teams, support personnel, and a tailormade ring-fenced and fire-walled infrastructure as per client specifications to support their  R&D  goals

        Know More
        Know More
    • Center for Advanced Protein Studies (CAPS)

      • Center for Advanced Protein Studies (CAPS)

        Centre for Advanced Protein Studies [CAPS] is a state-of-the-art advanced national facility located in the Syngene campus, Bangalore.

        Know More
        Know More
    • Investors
      Corporate Governance
  • Careers

Blogs

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

The Critical Role of Analytical Development: Supporting a Program with 70+ Method Validations
6th Nov, 2025
Read
Urban Mental Health: Evidence, Action, and Impact through BUMHI
5th Nov, 2025
Read
Cost of Goods Reduction by Design: Strategies for Early-Phase Process Optimization
31st Oct, 2025
Read
Computational toxicology – The new frontier in predictive safety assessment
Peptide synthesis and the hidden complexities of scaling peptide therapeutics, from SPPS to purification, analytics, and cGMP manufacturing. Talk to our team today.
16th Oct, 2025
Read
Project Optimus - Transforming the paradigm of dose optimization and selection in oncology
16th Oct, 2025
Read
Peptide synthesis and the hidden complexities of scaling peptide therapeutics
Peptide synthesis and the hidden complexities of scaling peptide therapeutics, from SPPS to purification, analytics, and cGMP manufacturing. Talk to our team today.
8th Oct, 2025
Read
How to choose a CRDMO at CPHI Frankfurt 2025: A Fieldguide
CPHI Frankfurt 2025 is the year’s most efficient place to compare science, scale, and reliability in one hall. Sponsors meet teams, see facilities represented across regions, and validate claims in real time.
24th Sep, 2025
Read
Syngene Enables Orocidin to Achieve Clinically Acceptable Antimicrobial Peptide
OROCIDIN A/S, a company focused on developing a novel treatment for advanced gum disease, or aggressive periodontitis, partnered with Syngene for the synthesis of their lead molecule
22nd Sep, 2025
Read
DMPK Unravelled: Breaking barriers in drug discovery
Time has always been the most serious concern in drug discovery, making it a race¾ not just to develop new treatments but also to deliver safe and effective medicines to patients more quickly.
16th Sep, 2025
Read
When Medicines Meet Sunlight: The Rise of In Silico Phototoxicity Testing
One of the less obvious risks in drug development is not how a medicine works inside the body, but how it behaves in the real world, particularly when exposed to sunlight.
15th Sep, 2025
Read

To view or email, Please share your details view

Download PDF
Download PDF

Your browser does not support this function.

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details